Closing soon

Notice of Intent: Measuring AAV9 Vector DNA in Mice Tissue Using QPCR RFP

Description: Preclinical trial, using our humanized mouse model of Hutchinson Gilford Progeria Syndrome (HGPS), testing the efficacy of therapeutic adenine DNA base editing, administered using Adeno-Associated Virus 9 (AAV9), for correcting the mutation that causes HGPS. This preclinical research is being used to support the application for the FDA Investigational New Drug (IND), SamPro-2, to treat HGPS patients in a Phase 1/2 clinical trial.

Buyer
Released
Oct 15, 2026
Closes
Oct 21, 2026(4 days left)

Files

Original attachments and procurement documents tied to this bid.

Federal RFP files are for Starbridge customers only.

You can request RFP files from all other buyer types for free on this site.

See your top accountsScan your site in seconds. Starbridge identifies your ICP and surfaces emerging opportunities from board meetings, job changes, new grants, contract expirations, RFPs, and more.
See your top 10 accounts